期刊文献+

牛磺酸对硫代乙酰胺致大鼠肝性脑病的保护作用

Protective Effect of Taurine Against Hepatic Encephalopathy Induced by Thioacetamide in Rats
原文传递
导出
摘要 目的探讨牛磺酸对硫代乙酰胺(TAA)诱导大鼠肝性脑病(HE)的保护作用。方法将24只健康雄性SPF级Wistar大鼠按体重随机分为3组,分别为空白对照组、HE模型组、牛磺酸+HE模型组,每组8只。牛磺酸+HE模型组给予牛磺酸(100 mg/kg)灌胃染毒,染毒容量为5 ml/kg,每天1次,连续染毒30 d;空白对照组、HE模型组给予等量生理盐水灌胃。30天后,HE模型组、牛磺酸+HE模型组腹腔注射TAA,首日剂量为300 mg/kg,随后剂量减半(150 mg/kg),染毒容量为5 ml/kg。空白对照组每天腹腔注射等量生理盐水。待HE大鼠出现无自主性活动或昏睡昏迷等症状时处死所有大鼠。检测血清3-硝基酪氨酸(3-NT)、丙二醛(MDA)、还原型谷胱甘肽(GSH)的含量及超氧化物歧化酶(SOD)、谷丙转氨酶(ALT)的活力;制作肝组织病理切片观察大鼠肝组织病理变化。结果与HE模型组比较,空白对照组和牛磺酸+HE模型组大鼠肝脏脏器系数较低,血清中ALT活力和3-NT、MDA含量较低,GSH含量和SOD活力较高,差异均有统计学意义(P<0.05),而空白对照组和牛磺酸+HE模型组大鼠肝脏脏器系数、血清中3-NT、MDA、GSH含量及SOD、ALT活力间比较,差异均无统计学意义。结论牛磺酸可以通过降低氧化-硝基化应激改善蛋白质和脂质化损伤,从而对TAA致大鼠HE起到保护作用。 Objective To investigate the protective effect of taurine against hepatic encephalopathy (HE) induced by thioacetamide in rats. Methods Twenty-four Wistar rats were randomly divided into 3 groups by weight (8 in each group): the blank control group,the HE model group,the taurine pretreated HE model group. The rats in the taurine pretreated HE model group were treated with taurine through gavage (5 ml/kg) once a day for 30 days with the dosage of 100 mg/kg, the rats in the blank control group and the HE model group were treated with the normal saline at the same volume. After 30 days,all the groups except the blank control group were treated with thioacetamide (5 ml/kg) by intraperitoneal injection once a day for 2 days with the dosage of 300 mg/kg at the first day and 150 mg/kg at the second day. At the same time the rats in the blank control group were treated with normal saline at the same dose. When HE rats appeared no independent activities or symptoms of lethargy and coma, they were sacrificed to collect blood for the detection of 3-nitrotyrosine (3-NT), malondialdehyde (MDA), superoxide dismutase (SOD) , reduced glutathione (GSH) and alanine aminotransferase (ALT). Pathological examination was conducted in the liver tissues. Results Compared with the HE group, the liver viscera coefficients and the serum contents of ALT,MDA,3-NT decreased conspicuously,and the GSH,SOD greatly increased in the black control group and taurine pretreated HE model group (P〈0.05),and there were no significant differences were seen in the above indices between the black control group and taurine pretreated HE model group. Conclusion In this study, taurine presented a protective effect against hepatic encephalopathy induced by thioacetamide in rats, in which decreasing oxidative and nitrosative stresses may be involved.
出处 《环境与健康杂志》 CAS CSCD 北大核心 2011年第8期686-689,F0003,共5页 Journal of Environment and Health
关键词 牛磺酸 肝性脑病 氧化-硝基化应激 Taurine Hepatic encephalopathy Oxidation-nitrosation
  • 相关文献

参考文献11

  • 1Chantal B, Paul D, Roger FB. Evidence for oxidative/nitrosative stress in the pathogenesis of hepatic encephalopathy [J]. Metab Brain Dis, 2010,25:3-9.
  • 2Huxtable RJ. Physiological actions of taurine [J]. Physical Rew, 1992,72: 101-163.
  • 3Seda MD, Yesim MD, Murat G, et al. Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet : Protective effect of taurine[ J ]. Basic Utritional Investigation, 2009,25 : 436-444.
  • 4刘辉,周瑞华,张爱娟,刘爱云.牛磺酸联合维生素E对小鼠酒精性肝损伤的保护作用[J].环境与健康杂志,2010,27(7):637-638. 被引量:2
  • 5Tsai-Ching H, Yi-Chen C, Chun-Chou T, et al. Protective effects of taurine against hepatic abnormality in NZB/W F1 mice fed a hypercholesterolemic diet [ J ]. Food Chemistry, 2009,119: 62-68.
  • 6Yasemin SK, Recep A. Taurine prevents nonylphenol-induced oxidative stress in rats[J ]. Journal of Animal and Veterinary Adwances,2010,9:37-43.
  • 7Shanmugam LD,Carani VA. Oxidative and nitrosative stress in experimental rat liver fibrosis:Protective effect of taurine [J] Environment al Toxicology and Pharmacology, 2010,29:104-110.
  • 8邵丽华,汪心婷,马立宪,孙淑爱,王淑娥,潘玉珍.肝性脑病大鼠肝和脑组织一氧化氮及一氧化氮合酶的研究[J].山东大学学报(医学版),2003,41(3):257-259. 被引量:5
  • 9郭帅,邵丽华,荣琳,王希峰,郗德凤.固相萃取-高效液相色谱荧光检测法测定人血浆3-硝基酪氨酸含量[J].分析化学,2009,37(2):242-246. 被引量:7
  • 10刘厚钰,石虹.肝性脑病发病机制的新进展[J].现代消化及介入诊疗,2009,14(2):92-94. 被引量:11

二级参考文献44

  • 1Ryberg H, Caidahl K. J. Chromatogr. B, 2007, 851(1/2) : 160 - 171
  • 2Tsikas D, Caidahl K. J. Chromatogr. B, 2005, 814(1): 1 -9
  • 3Duncan M W. Amino Acids, 2003, 25(3/4) : 351 -361
  • 4Herce-Pagliai C, Kotecha S, Shuker D E. Nitric Oxide, 1998, 2 (5) : 324 -336
  • 5Radi R. Proc. Natl. Acad. Sci. USA, 2004, 101(12): 4003-4008
  • 6Du M, Wu W, Ercal N, Ma Y. J. Chromatogr. B, 2004, 803(2) : 321 -329
  • 7Uchiyama S, Santa T, Okiyama N, Fukushima T, Imai K. Biomed. Chromatogr. 2001, 15(5) : 295 -318
  • 8Zhu X L, Shaw P N, Barrett D A. Anal. Chim. Acta, 2003, 478(2) : 259-269
  • 9Cerietlo A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Diabetologia, 2001, 44(7): 834-838
  • 10Wang X L, Rainwater D L, Leone A, Mahaney M C. Diabet Med. , 2004, 21(6) : 577 -580

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部